 outcomes) along with
the eligibility criteria in the Table. The Ô¨Åve questions
addressed medical management vs carotid revascularization (CEA) in asymptomatic patients, CEA vs CAS in
symptomatic low surgical risk patients, the optimal
timing of revascularization after acute stroke, screening
high-risk patients for carotid disease, and the optimal
sequence of interventions in patients with combined
coronary and carotid disease.
Data sources and search